Education
About Us
Working with TipRanks
Follow Us
Labcorp Holdings (LH)
NYSE:LH
LH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$191.97 - $258.59
Previous CloseN/A
Volume103.18K
Average Volume (3M)606.14K
Market Cap
$19.39B
Enterprise Value$25.08B
Total Cash (Recent Filing)$1.52B
Total Debt (Recent Filing)$1.94B
Price to Earnings (P/E)26.4
Beta0.46
Next Earnings
Apr 24, 2025EPS Estimate
3.79Last Dividend Ex-Date
Feb 27, 2025Dividend Yield1.23%
Share Statistics
EPS (TTM)8.84
Shares Outstanding83,700,000
10 Day Avg. Volume567,649
30 Day Avg. Volume606,137
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)N/A
Price to Sales (P/S)1.51
Price to Cash Flow (P/CF)6.30
P/FCF Ratio6.90
Enterprise Value/Market Cap1.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.16
Enterprise Value/Ebitda14.08
Forecast
1Y Price Target
$278.38Price Target Upside20.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
---
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceLabcorp Holdings posted solid fourth-quarter results, surpassing expectations with sales of $3.33 billion and adjusted EPS of $3.45.
Financial HealthLabcorp Holdings has significant cash reserves and authorized share repurchase, indicating strong financial health and strategic flexibility.
Strategic GrowthMergers and acquisitions remain a strategic focus, contributing significantly to growth and supported by a robust pipeline of potential deals.
Bears Say
Backlog ConcernsBacklog decreased ~3.2% due to foreign exchange.
Margin PressureMargins were light on transient items despite solid sales and EPS performance.
---
Ownership Overview
0.31% Insiders
28.50% Mutual Funds
23.36% Other Institutional Investors
23.46% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LH FAQ
What was Labcorp Holdings’s price range in the past 12 months?
Labcorp Holdings lowest stock price was $191.97 and its highest was $258.59 in the past 12 months.
What is Labcorp Holdings’s market cap?
Labcorp Holdings’s market cap is $19.39B.
When is Labcorp Holdings’s upcoming earnings report date?
Labcorp Holdings’s upcoming earnings report date is Apr 24, 2025 which is in 27 days.
How were Labcorp Holdings’s earnings last quarter?
Labcorp Holdings released its earnings results on Feb 06, 2025. The company reported $3.45 earnings per share for the quarter, beating the consensus estimate of $3.392 by $0.058.
Is Labcorp Holdings overvalued?
According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued.
Does Labcorp Holdings pay dividends?
Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.23%. See more information on Labcorp Holdings dividends here
What is Labcorp Holdings’s EPS estimate?
Labcorp Holdings’s EPS estimate is 3.79.
How many shares outstanding does Labcorp Holdings have?
Labcorp Holdings has 83,700,000 shares outstanding.
What happened to Labcorp Holdings’s price movement after its last earnings report?
Labcorp Holdings reported an EPS of $3.45 in its last earnings report, beating expectations of $3.392. Following the earnings report the stock price went down -0.903%.
Which hedge fund is a major shareholder of Labcorp Holdings?
Currently, no hedge funds are holding shares in LH
---
Labcorp Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$278.38 (20.16% Upside)
$278.38 (20.16% Upside)
Blogger Sentiment
Neutral
LH Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 19.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $805.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.2%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.33%
12-Months-Change
Fundamentals
Return on Equity
9.37%
Trailing 12-Months
Asset Growth
9.89%
Trailing 12-Months
Company Description
Labcorp Holdings
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
---
LH Company Deck
---
LH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong revenue growth across diagnostics and biopharma segments, successful acquisitions, and promising guidance for 2025. However, there are concerns about margin decline due to acquisitions and higher personnel costs.Read More>---
LH Revenue Breakdown
77.42% Dx
22.81% BLS
---
LH Stock 12 Month Forecast
Average Price Target
$278.38
▲(20.16% Upside)
Technical Analysis
Best Analysts Covering LH
1 Year
1 Year Success Rate
19/22 ratings generated profit
1 Year Average Return
+14.26%
reiterated a buy rating 3 months ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +14.26% per trade.
---